论文部分内容阅读
目的研究分析血塞通与脉络宁用于脑梗死的临床应用价值。方法选择我院收治的脑梗死患者112例,随机分成研究组(n=56)与对照组(n=56),对照组运用血塞通药物注射治疗,研究组采用脉络宁药物注射治疗,比较分析两组患者的临床治疗效果。结果研究组的治疗总有效率为96.4%,明显高于对照组(P<0.05);对照组患者在治疗期间有2例患者出现了输液不良反应;研究组没有1例出现不良反应。结论脉络宁药物用于脑梗死患者临床治疗效果更佳,不良反应少,值得推广与应用。
Objective To study the clinical value of Xuesaitong and Mailuoning on cerebral infarction. Methods A total of 112 patients with cerebral infarction admitted to our hospital were randomly divided into study group (n = 56) and control group (n = 56). The control group was treated with Xuesaitong injection. The study group was treated with Mailuoning injection. Analysis of two groups of patients with clinical treatment. Results The total effective rate of the study group was 96.4%, which was significantly higher than that of the control group (P <0.05). Two patients in the control group had adverse reactions of infusion during the treatment period and none of the patients in the study group had adverse reactions. Conclusion Mailuoning drug for cerebral infarction in patients with better clinical outcomes, fewer adverse reactions, it is worth promoting and application.